Lopressor

AssetAlso called CGP-2175, CGP-2175E, NSC-757105, Metoprolol

Stage: Approved
Modality: Not known
Target: ADRB1; 4
Indications: 106
Trials: 1
Developer

Approved by the FDA on Aug 7, 1978 (NDA017963). 5 approvals stand. FDA

Indications

4

Myocardial infarction
Approved, FDA
Acute myocardial infarction
Approved, FDA
Angina pectoris
Approved, FDA

1 more

In the full profile

Target and mechanism2
Owner and partners1
Trials106
Evidence for its targets2
Competitors12
Aging relevance1
Signals7

Every asset’s record: target, stage, trials and the evidence behind it.